Mirae Asset Global Etfs Holdings Ltd. Aurinia Pharmaceuticals Inc. Put Options Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AUPH
# of Institutions
194Shares Held
56.1MCall Options Held
418KPut Options Held
618K-
Armistice Capital, LLC New York, NY11.1MShares$92.2 Million0.83% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$76.8 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32.9 Million2.14% of portfolio
-
State Street Corp Boston, MA2.88MShares$23.8 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.78MShares$23 Million1.94% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.17B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...